ELISKARDIA

This brand name is authorized in Estonia, Croatia, Lithuania, Romania

Active ingredients

The drug ELISKARDIA contains one active pharmaceutical ingredient (API):

1 Prasugrel UNII 34K66TBT99 - PRASUGREL

Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke. Read about Prasugrel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC22	Prasugrel	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1741193, 1741205, 1741216, 1741227, 1741238, 1741249, 1741250, 1741261, 1741272, 1741283, 1741294, 1741306, 1741317, 1741328, 1741339, 1741340
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-264927020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086154, 1086155, 1086156, 1086157, 1086158, 1086159, 1086160, 1086161, 1086162, 1086163, 1086164, 1086165, 1086166, 1086167, 1086168, 1086169
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65533001, W65533002, W65533003, W65533004, W65533005, W65533006, W65533007, W65533008